Rachel Gowland, 19 July 2021
Health Education England elearning for healthcare (HEE elfh) has worked in partnership with a range of health organisations including the Advanced Therapy Treatment Centre Network and London Advanced Therapies to develop a new elearning programme for healthcare professionals on advanced therapies.
Advanced therapy medicinal products (ATMPs) are medicines for human use which use genes, tissues or cells to offer ground-breaking new opportunities for the treatment of disease and injury. They can offer the promise of treating and altering the course of diseases which cannot be addressed adequately by existing pharmaceuticals, offering a lifeline to some patients who may have exhausted all other treatment options.
This programme of elearning sessions is designed give the learner a core understanding of cell and gene therapies, the biology involved in these treatments and how they work. The modules take the learner from the basics of cell and gene therapy and different modalities of treatment, to an in-depth look at treatments currently being delivered through commissioned treatment and clinical trials.
Learners will also be introduced to the unique challenges of bringing these pioneering advanced therapy treatments to patients, including logistical and handling requirements.
The sessions, which each last approximately 30 minutes, cover the following topics:
- Introduction to advanced therapy medicinal products
- In vivo gene therapies
- Immune effector cell therapy
- Focus on CAR-T cell therapy
- The logistics of ATMPs in hospitals
- Safe use of low temperature transport vessels
For more information and to access the sessions, visit the Advanced Therapy Medicinal Products programme page.
Comments are closed.